Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.52
-0.17 (-2.54%)
Jul 6, 2026, 4:00 PM EDT - Market closed
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $426.36 million as of July 7, 2026. Its market cap has increased by 170.04% in one year.
Market Cap
426.36M
Enterprise Value
319.62M
1-Year Change
170.04%
Ranking
Category
Stock Price
$6.52
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $426.36M, an increase of 591.94%. That is a compound annual growth rate of 43.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 426.36M | 11.84% |
| Dec 31, 2025 | 381.21M | 241.41% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
| Mar 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evommune | 445.19M |
| Adlai Nortye | 436.80M |
| Rocket Pharmaceuticals | 435.68M |
| Autolus Therapeutics | 433.81M |
| Century Therapeutics | 432.85M |
| DiaMedica Therapeutics | 431.61M |
| vTv Therapeutics | 428.69M |
| Enanta Pharmaceuticals | 421.93M |